@article{b6cb509f5b384ee68aef4d58c3c4762b,
title = "The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy",
abstract = "N/A",
keywords = "Aminobutyrates, Angiotensin Receptor Antagonists, Biphenyl Compounds, Drug Combinations, Humans, Hypertension, Neprilysin, Stroke Volume, Tetrazoles, Valsartan, Heart Failure, Hypertrophy, Aminobutyrates, Angiotensin Receptor Antagonists, Biphenyl Compounds, Drug Combinations, Humans, Hypertension, Neprilysin, Stroke Volume, Tetrazoles, Valsartan, Heart Failure, Hypertrophy",
author = "Filippo Crea",
year = "2021",
doi = "10.1093/eurheartj/ehab627",
language = "English",
volume = "42",
pages = "3581--3585",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford : Oxford University Press United Kingdom: Harcourt Publishers Limitedinternational.com, Fax: 011 44 20 83085876",
}